The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated survival data and biomarker assessment of the CBCSG006 trial: A randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer.
 
Jian Zhang
No Relationships to Disclose
 
Ying Lin
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose
 
Wentao Yang
No Relationships to Disclose
 
Xiangjie Sun
No Relationships to Disclose
 
Biyun Wang
No Relationships to Disclose
 
Zhonghua Wang
No Relationships to Disclose
 
Jianfeng Luo
No Relationships to Disclose
 
Leiping Wang
No Relationships to Disclose
 
Sheng Zhang
No Relationships to Disclose
 
Jun Cao
No Relationships to Disclose
 
Zhonghua Tao
No Relationships to Disclose
 
Jiong Wu
No Relationships to Disclose
 
Zhimin Shao
No Relationships to Disclose